FDA指南清单 |
序号 | 中文文件名称 | 原文文件名称 |
1 | 上市前批准申请模块审核 | Premarket Approval Application Modular Review |
2 | 医疗器械的电子副本提交程序 | eCopy Program for Medical Device Submissions |
3 | 上市前批准申请中制造信息和运营的审查与检查 | The Review and Inspection of Premarket Approval Application Manufacturing Information and Operations |
4 | 无菌类器械上市前通告(510(k))申报中关于无菌证明资料的提交及审查 | Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile |
5 | 电池指南 | Battery Guidelines |
6 | 着色剂申请 | Color Additive Petitions |
7 | 移动医疗的应用 | Mobile Medical Applications |
8 | 设备标签指南 | Device Labeling Guidance |
9 | 免疫毒性试验指南 | Immunotoxicity Testing Guidance |
10 | 软件验证的一般原则 | General Principles of Software Validation |
11 | 现成医疗器械软件的使用 | Off-The-Shelf Software Use in Medical Devices |
12 | 医疗设备和EMI:FDA观点 | Medical Devices and EMI: The FDA Perspectiv |
13 | 儿科用医疗器械的上市前评估 | Premarket Assessment of Pediatric Medical Devices |
14 | 一般健康:低风险设备的政策 | General Wellness: Policy for Low Risk Devices |
15 | 含乳胶的医疗器械标注乳胶标识 | The labels of certain medical devices to declare latex content |
16 | 无线医疗遥测的风险和建议 | Wireless Medical Telemetry Risks and Recommendations |
17 | 含有防锐器损伤特性的医疗器械 | Medical Devices with Sharps Injury Prevention Features |
18 | 医疗器械关键临床研究的设计考虑因素 | Design Considerations for Pivotal Clinical Investigations for Medical Devices |
19 | 医疗器械临床研究中特定性别数据的评价 | Evaluation of Sex-Specific Data in Medical Device Clinical Studies |
20 | 医疗器械网络安全管理的上市前提交内容 | Content of Premarket Submissions for Management of Cybersecurity in Medical Devices |
21 | 保护性限制的上市前通知提交的内容指南 | Guidance On the Content Of Premarket Notification [510(K)] Submissions for Protective Restraints |
22 | 含现有(OTS)软件的网络化医疗设备的网络安全 | Cybersecurity for Networked Medical Devices Containing Off-the-Shelf (OTS) Software |
23 | 应用人为因素和可用性工程优化医疗器械设计 | Applying Human Factors and Usability Engineering to Medical Devices |
24 | 对于含有软件的医疗器械的上市前申请内容的指南 | Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices |
25 | 加工、再加工医疗器械的医疗关键点:验证方法和标识 | Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling |
26 | 认定510(k)器械预期用途;CDRH工作人员指南(更新至K98-1) | Determination of Intended Use for 510(k) Devices; Guidance for CDRH Staff (Update to K98-1) |
27 | 含有天然橡胶器械的用户标识(21 CFR 801.437);小型实体合规指南 | User Labeling for Devices that Contain Natural Rubber (21 CFR 801.437); Small Entity Compliance Guide |
28 | 医疗设备数据系统、医疗图像存储设备和医疗图像通信设备 | Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices |
29 | 用于告知用户产品或产品容器并非由天然胶乳制成的医疗产品标识建议 | Recommendations for Labeling Medical Products to Inform Users that the Product or Product Container is not Made with Natural Rubber Latex |
30 | 国际标准ISO-10993,"医疗器械的生物学评价第1部分:评价和检验"的使用 | Use of International Standard ISO-10993, "Biological Evaluation of Medical Devices Part 1: Evaluation and Testing" |
31 | 医疗器械早期可行性临床研究(包括首次应用于人类研究)的器械临床研究豁免(IDE) | Investigational Device Exemptions (IDE) for Early Feasibility Medical Device Clinical Studies, Including Certain First in Human (FIH) Studies |
32 | 《关于在卫生保健机构中使用的灭菌器上市前通知[510(k)]提交资料意见的指南》附录 | Addendum to: Guidance on Premarket Notification [510(k)] Submissions for Sterilizers Intended for Use in Health Care Facilities |
33 | 通信系统(动力和非动力)和动力环境控制系统准备上市前通知[510(k)]申请的指南 | Guidance Document for The Preparation of Premarket Notification [510(K)] Applications for Communications Systems (Powered and Non-Powered) and Powered Environmental Control Systems |
34 | 医疗器械有效期 | Shelf Life of Medical Devices |
35 | 医疗器械申请资料审核期间的沟通类型 | Types of Communication During the Review of Medical Device Submissions |
36 | 在美国境外实施研究所获得医疗器械临床数据的验收 | Acceptance of Medical Device Clinical Data from Studies Conducted Outside the United States |
37 | 医疗器械上市前申请自愿共识标准的合理使用 | Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices |
38 | 评估用户费用:PMA补充申请定义、模块化PMA费用、BLA和功效补充申请定义、一份申请中捆绑多个器械以及组合产品的费用 | Assessing User Fees PMA Supplement Definitions, Modular PMA Fees, BLA and Efficacy Supplement Definitions, Bundling Multiple Devices in a Single Application |
39 | 平衡需接受上市前审批的器械的上市前和上市后数据收集行业及美国食品药品管理局工作人员指南 | Balancing Premarket and Postmarket Data Collection for Devices Subject to Premarket Approval-Guidance for Industry and Food and Drug Administration Staff |
40 | 决定具备不同技术特征器械的上市前通知[510(k)]实质等同性中需考虑的效益和风险因素 | Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications [510(k)] with Different Technological Characteristics |
41 | CDRH有关待认可候选共识标准的识别和评价的标准操作程序 | CDRH Standard Operating Procedures for the Identification and Evaluation of Candidate Consensus Standards for Recognition |
42 | 重新审理分类过程(III类器械自动命名评估) | De Novo Classification Process (Evaluation of Automatic Class III Designation) |
43 | 何时为现有器械变更申报510 (k)的决定 | Deciding When to Submit a 510(k) for a Change to an Existing Device |
44 | 交互操作医疗器械的设计考量和上市前提交建议 | Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices |
45 | 医疗器械生产商的设计控制指南 | Design Control Guidance For Medical Device Manufacturers.pdf |
46 | 临床研究者财务披露 | Guidance for Clinical Investigators, Industry, and FDA Staff-Financial Disclosure by Clinical Investigators.pdf |
47 | 机构审查委员会(IRB)指南-常见问题 – IRB 注册 | Guidance for Institutional Review Boards (IRBs)- Frequently Asked Questions – IRB Registration.pdf |
48 | 关于接收非实质等同性(NSE)信函的再处理一次性使用器械(SUD)状况的常见问题(FAQ) | Frequently Asked Questions (FAQs) on the Status of Reprocessed Single Use Devices (SUDs) that receive a Not Substantially Equivalent (NSE) Letter.pdf |
49 | 共识标准认可的常见问题 | Frequently Asked Questions on Recognition of Consensus Standards.pdf |
50 | 医疗器械动物研究总则 | General Considerations for Animal Studies for Medical Devices |
51 | 全球唯一医疗器械标识数据库(GUDID) | Global Unique Device Identification Database (GUDID) |
52 | 全球唯一医疗器械标识数据库(GUDID):2015年9月24日数据提交合规日期 | Global Unique Device Identification Database (GUDID) Data Submission Compliance Date of September 24, 2015 |
53 | 良好进口商规范 | Good Importer Practices |
54 | 关于已获批准的药品和已获批准或许可的医疗器械的未经批准的新用途的医学期刊论文学或科学参考出版物分销的良好重印规范 | Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New |
55 | 制造方法或工艺变更的30天通知、135天上市前批准(PMA)补充申请和75天人道主义器械豁免(HDE)补充申请 | 30-Day Notices, 135-Day Premarket Approval (PMA) Supplements and 75-Day Humanitarian Device Exemption (HDE) Supplements for Manufacturing Method or Process Changes |
56 | 共识标准的认可和使用 | Recognition and Use of Consensus Standards |
57 | 单个提交中多种器械或多种适应症的捆绑 | Bundling Multiple Devices or Multiple Indications in a Single Submission |
58 | 传统和简易510(k)的格式 | Format for traditional and Abbreviated 510(k)s |
59 | FDA和行业关于上市前通知(510(k))提交的行动:对FDA审查时间和目标的影响 | FDA and Industry Actions on Premarket Notification (510(k)) Submissions Effect on FDA Review Clock and Goals |
60 | 上市前通知提交(510(k))用户费用及退款 | User Fees and Refunds for Premarket Notification Submissions (510(k)s) |
61 | 513(g)信息请求的用户费 | Guidance for Industry and Food and Drug Administration Staff - User Fees for 513(g) Requests for Information |
62 | 实质等同性决定中标准的使用 | Use of Standards in Substantial Equivalence Determinations |
63 | 关于新510(k)范例的常见问题 | FREQUENTLY ASKED QUESTIONS ON THE NEW 510(k) PARADIGM |
64 | 一般特殊预期使用 | General Specific Intended Use |
65 | 第三方及FDA工作人员指南;上市前通知第三方审核 | Guidance for Third Parties and FDA Staff; Third Party Review of Premarket Notifications |
66 | FDA在2000年日期问题方面对医疗器械制造商的要求指南 | Guidance on FDA's Expectations of Medical Device Manufacturers Concerning the Year 2000 Date Problem.pdf |
67 | 医疗器械患者标签指南 | Guidance on Medical Device Patient Labeling |
68 | 关于向用于单次使用器械进行预期由原始制造商进行的再加工的医院报告的不良事件指南 | Guidance on Adverse Event Reporting for Hospitals that Reprocess Devices Intended by the Original Equipment Manufacturer for Single Use |
69 | 如何准备认证用预申请(Pre-RFD)行业指南草稿 | How to Prepare a Pre-Request for Designation (Pre-RFD) Draft Guidance for Industry.pdf |
70 | 如何准备认证申请(RFD) | How to Write a Request for Designation (RFD) |
71 | 与器械标签相关的人为因素原则 | HUMAN FACTORS PRINCIPLES FOR MEDICAL DEVICE LABELING |
72 | 适应症声明 | Indications for Use Statement.pdf |
73 | 豁免某些未分类、II类和I类保留医疗器械上市前通知要求的意图 | Intent to Exempt Certain Unclassified, Class II, and Class I Reserved Medical Devices from Premarket Notification Requirements.pdf |
74 | 联邦食品、药品和化妆品法案第201(h)条器械定义中术语"化学作用"的解释-指南草案 | Interpretation of the Term"Chemical Action" in the Definition of Device under Section 201(h) of the Federal Food, Drug, and Cosmetic Act DRAFT GUIDANCE This guid.pdf |
75 | 标签医疗器械监管要求 | Labeling Regulatory Requirements for Medical Devices |
76 | 电子防盗系统的标签 | Labeling for Electronic Anti-Theft Systems |
77 | 利用现有临床数据推断医疗器械的儿科用途 | Leveraging Existing Clinical Data for Extrapolation to Pediatric Uses of Medical Devices |
78 | 人为因素审核最高优先级器械清单 | List of Highest Priority Devices for Human Factors Review |
79 | 制造地点变更补充材料:内容与提交 | Manufacturing Site Change Supplements Content and Submission |
80 | 第III部分 – 科学和技术信息指南 | PART III- GUIDANCE ON SCIENTIFIC AND TECHNICAL INFORMATION |
81 | 医疗器械附件——描述配件及新配件类型的分类途径 | Medical Device Accessories–Describing Accessories and Classification Pathway for New Accessory Types |
82 | 医疗器械分类产品代码 | Medical Device Classification Product Codes |
83 | 医疗器械开发工具 | Medical Device Development Tools |
84 | 制造商的医疗器械报告 | Medical Device Reporting for Manufacturers |
85 | 使用机构的医疗器械报告 | Medical Device Reporting for User Facilities |
86 | 医疗器械追踪 | Medical Device tracking |
87 | 医疗器械上市后的网络安全管理 | Postmarket Management of Cybersecurity in Medical Devices |
88 | 《联邦食品、药品和化妆品法案》第552节下的上市后监督 | Postmarket Surveillance Under Section 522 of the Federal Food, Drug, and Cosmetic Act |
89 | 510(k)拒绝接受政策 | Refuse to Accept Policy for 510(k)s |
90 | 医疗器械申报材料中关于计算建模研究的报告 | Reporting of Computational Modeling Studies in Medical Device Submissions |
91 | 关于现有型号系列中新型号的报告 | Reporting of New Model Numbers to Existing Model families |
92 | 510(k)计划:在上市前通知[510(k)]中评价实质等同性 | The 510(k) Program Evaluating Substantial Equivalence in Premarket Notifications [510(k)]-Guidance for Industry and Food and Drug Administration Staff |
93 | 良好实验室管理实践在器械上市前认证中的适用性:问答 | The Applicability of Good Laboratory Practice in Premarket Device Submissions Questions & Answers |
94 | 新510(K)-在上市前通知中证明实质等同性的替代方法 | The New 510(k) Paradigm-Alternate Approaches to Demonstrating Substantial Equivalence in Premarket Notifications |
95 | 毒理学风险评估委员会#G89-1(蓝皮书备忘录)(纯文本) | Toxicology Risk Assessment Committee #G89-1 (blue book memo) (Text Only) |
96 | 上市前通知(510(k))认证的传递-问答 | transfer of a Premarket Notification (510(k)) Clearance – Questions and Answers-Draft Guidance for Industry and Food and Drug Administration Staff |
97 | 唯一器械标识系统:唯一器械标识符(UDI)的形式和内容 | Unique Device Identification System:Form and Content of the Unique Device Identifier (UDI) |
98 | 唯一医疗器械标识系统:小型企业合规指南 | Unique Device Identification System:Small Entity Compliance Guide |
99 | 唯一器械标识:器械直接标记 | Unique Device Identification: Direct Marking of Devices |
100 | 唯一器械标识号系统 常见问题, 第1卷 | Unique Device Identifier System Frequently Asked Questions, Vol. 1 |
101 | 使用真实应用证据来支持对医疗器械作出监管决策 | Use of Real-World Evidence to Support Regulatory Decision-Making for Medical DevicesAdministration Staff |
102 | 使用说明中危险警告的翻版 | Reproduction of Hazard Warnings in User Instructions |
103 | 与制造商报告编号格式的差异 – 编号5 | Variance from Manufacturer Report Number Format - No. 5 |
104 | 医疗器械中的射频无线技术 | Radio Frequency Wireless Technology in Medical Devices |
105 | 医学影像管理器械上市前通告申报指南 | Guidance for the Submission Of Premarket Notifications for Medical Image Management Devices |
106 | 关于"包含现成(OTS)软件的网络化医疗器械的网络安全"行业指南的医疗机构用信息 | Information for Healthcare Organizations about FDA's Guidance for Industry Cybersecurity for Networked Medical Devices Containing Off-The-Shelf (OTS) Software |
107 | 支持电动医疗器械电磁兼容性(EMC)声明的资料 | Information to Support a Claim of Electromagnetic Compatibility (EMC) of Electrically-Powered Medical Devices |
108 | 卫生和公众服务部 - 灯具兼容性政策 | DEPARTMENT OF HEALTH & HUMAN SERVICES - POLICY ON LAMP COMPATIBILITY |
109 | 医疗激光产品使用说明 | User Instructions for Medical LASER Products |
110 | 合格评定认可计划 (ASCA) 试点计划 | The Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program |
111 | 医疗器械提交的反馈请求和会议:Q-提交计划 | Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program |
112 | 医疗器械的电磁兼容性 (EMC) | Electromagnetic Compatibility (EMC) of Medical Devices |